Danish drugmaker Novo Nordisk will offer cheaper insulin to U.S. diabetics in response to criticism over the high price of the medication and after similar moves by rivals Sanofi and Eli Lilly.

The U.S. FDA approved Regeneron Pharmaceuticals Inc.’s Eylea (aflibercept) Injection for all stages of diabetic retinopathy, which is the leading cause of vision loss in diabetic patients.

People with diabetes are more likely to report back and neck pain, but it’s still unclear if diabetes is the cause of their pain, a research review concludes.

One in seven people with type 2 diabetes may be needlessly testing their blood sugar at home several times a day, a U.S. study suggests.

The cost of insulin prevents many people with diabetes from taking it as directed, a small survey suggests.